Hot or Not, Stock Market Edition: 09/04/2025

From yacht stocks that are rockin’ to a dismal downgrade for a well-known financial firm, here are some of the stocks making moves right now:

• Hot: MasterCraft Boat Holdings (MCFT) is sailing following an earnings beat; PagerDuty (PD) could see 40% upside in the coming year
• Not: UBS Group (UBS) gets a downgrade; in biotechs, Aardvark Therapeutics (AARD) is one to avoid

P.S. For more stocks making moves, check out our Zen Ratings Upgrades & Downgrades screener.

A note from our sponsors...

The ONLY AI opportunity you should be looking at

This is the ONLY AI wealth-building opportunity you should be watching right now.

No. It's not about Nvidia, Tesla, or Meta...

It's about one overlooked company profiting off AI "digital goldmines" that are poised to experience 100x growth very soon.

This new opportunity will change the market and make investors a lot of money.

That's why it has received a $500 billion commitment from President Trump himself...

Learn more about this little-known company here >>>

🔥 HOT: MasterCraft Boat Holdings (NASDAQ: MCFT) may not be the “king of the world,” but this recreational powerboat maker definitely has good juju right now. The company recently smashed earnings and revenue expectations, boosting investor confidence despite a drop in overall revenue. It’s the #1 stock in the Recreational Vehicle category on WallStreetZen, which we currently rank as an above-average industry. The stock itself has a Zen Rating of A, ranking in the top 3% of stocks we track based on 115 factors proven to drive stock growth. A Growth rating of A sets it apart in its sector, with solid B ratings for Value, Sentiment and Financials. The verdict: Strong Buy. 

🥶 NOT: Aardvark Therapeutics (NASDAQ: AARD) is an experimental biotech with a nose for new therapies, but right now, it’s not exactly digging up gold. A lack of significant news or breakthroughs is keeping AARD on the cold list, with market trends favoring bigger biotech names (for better options, check out our Biotech Stocks to Buy Now screener). Right now, AARD has the lowest possible Zen Rating of F, ranking in the lowest 5% of stocks we track, with major red flags showing in its Value rating and Growth rating of D. 

🔥 HOT: PagerDuty (NASDAQ: PD) provides a crucial service in this day and age: digital operations management for IT teams that aim to prevent disasters before anyone even notices. The stock is up 12% in the past 3 months, with forecasts suggesting over 40% potential upside in the next year. With an overall Zen Rating of A, it’s in a class of stocks that have historically delivered 32.52% annual returns — digging deeper into its Component Grades, it has an excellent (A) rating for Growth, and currently ranks an impressive #5 out of the 200 stocks WallStreetZen tracks in the App industry. 

> Read more about our Growth ratings here

🥶 NOT: UBS Group AG (NYSE: UBS) may be a global banking giant, but it’s looking a little frostbitten right now. WallStreetZen recently downgraded the stock from a Zen Rating of C (Hold) to a D (Sell), signaling weakening fundamentals and investor caution. Among recent negative catalysts? Advisor attrition in its Wealth Management division, linked to compensation changes UBS implemented in December 2024, which reduced payouts for certain advisors. UBS also faces headwinds from a tougher rate environment, volatile markets, and cooling sentiment in the financial sector. With its cooling Zen Rating and no standout scores among its Component Grades, the verdict is clear: avoid for now. 

A note from our sponsors...

What to Do Next?

• 77 Best Stocks NOW! >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.